Featured News
Articles, videos, and features highlighting the work of Center investigators
– NatureSystems vaccinology of the BNT162b2 mRNA vaccine in humans - Nature
Profiling the immune responses of 56 volunteers vaccinated with BNT162b2 reveals how this mRNA vaccine primes the innate immune system to mount a potent response to SARS-CoV-2 after booster immunization.
– ScienceShared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues
Blood taken from children before the COVID-19 pandemic contains memory B cells that bind SARS-CoV-2.
– News CenterCOVID-19 severity affected by proportion of antibodies targeting crucial viral protein, study finds
A comprehensive study of immune responses to SARS-CoV-2 associates mild disease with comparatively high levels of antibodies that target the viral spike protein. But all antibodies wane within months.
- – KRCR
Stanford researchers conduct COVID-19 study in Redding
Because of the determination of a Redding doctor, a Stanford-based clinical trial for a potential COVID-19 treatment got underway Friday afternoon. Dr. Jayakar Nayak and his team of researchers flew into Redding and got right to work testing the effectiveness of povidone-iodine, better known as betadine, in killing the coronavirus through a nasal spray.
– News CenterCoronavirus likely infects upper airway cells first; blood pressure drugs unlikely to increase risk
A Stanford Medicine study reports that the coronavirus likely first infects upper airway cells and that hypertension drugs probably don't increase the risk of infection.